Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Robertson, John A.
2010.
Law, Science, and Innovation: Introduction to the Symposium.
Journal of Law, Medicine & Ethics,
Vol. 38,
Issue. 2,
p.
175.
Bubela, Tania
Li, Matthew D
Hafez, Mohamed
Bieber, Mark
and
Atkins, Harold
2012.
Is belief larger than fact: expectations, optimism and reality for translational stem cell research.
BMC Medicine,
Vol. 10,
Issue. 1,
Caulfield, Timothy
Rachul, Christen
and
Zarzeczny, Amy
2012.
The Evolution of Policy Issues in Stem Cell Research: An International Survey.
Stem Cell Reviews and Reports,
Vol. 8,
Issue. 4,
p.
1037.
Hammersla, A.M.
and
Rohrbaugh, M.L.
2012.
Progenitor and Stem Cell Technologies and Therapies.
p.
121.
Master, Zubin
and
Resnik, David B.
2013.
Hype and Public Trust in Science.
Science and Engineering Ethics,
Vol. 19,
Issue. 2,
p.
321.
Burningham, Sarah
Ollenberger, Adam
and
Caulfield, Timothy
2013.
Commercialization and Stem Cell Research: A Review of Emerging Issues.
Stem Cells and Development,
Vol. 22,
Issue. S1,
p.
80.
Bubela, Tania
and
McCabe, Christopher
2013.
Value-Engineered Translation for Regenerative Medicine: Meeting the Needs of Health Systems.
Stem Cells and Development,
Vol. 22,
Issue. S1,
p.
89.
Critchley, Christine R.
Bruce, Gordana
and
Farrugia, Matthew
2013.
The Impact of Commercialisation on Public Perceptions of Stem Cell Research: Exploring Differences Across the Use of Induced Pluripotent Cells, Human and Animal Embryos.
Stem Cell Reviews and Reports,
Vol. 9,
Issue. 5,
p.
541.
Master, Zubin
and
Resnik, David B.
2013.
Promoting Public Trust: ESCROs Won't Fix the Problem of Stem Cell Tourism.
The American Journal of Bioethics,
Vol. 13,
Issue. 1,
p.
53.
King, Nancy MP
and
Perrin, Jacob
2014.
Ethical issues in stem cell research and therapy.
Stem Cell Research & Therapy,
Vol. 5,
Issue. 4,
Smith, E.
and
Master, Z.
2014.
Reference Module in Biomedical Sciences.
Moreno, Palmira Granados
and
Joly, Yann
2015.
Principles of Translational Science in Medicine.
p.
281.
Caulfield, Timothy
and
Ogbogu, Ubaka
2015.
The commercialization of university-based research: Balancing risks and benefits.
BMC Medical Ethics,
Vol. 16,
Issue. 1,
Mittra, J.
Tait, J.
Mastroeni, M.
Turner, M.L.
Mountford, J.C.
and
Bruce, K.
2015.
Identifying viable regulatory and innovation pathways for regenerative medicine: a case study of cultured red blood cells.
New Biotechnology,
Vol. 32,
Issue. 1,
p.
180.
Ghosh, Debabrata
Mehta, Nalin
Patil, Asmita
and
Sengupta, Jayasree
2016.
Ethical issues in biomedical use of human embryonic stem cells (hESCs).
Journal of Reproductive Health and Medicine,
Vol. 2,
Issue. ,
p.
S37.
Weinryb, Noomi
and
Bubela, Tania
2016.
Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South Korea.
Stem Cell Reviews and Reports,
Vol. 12,
Issue. 1,
p.
8.
McNutt, Kathleen
and
Zarzeczny, Amy
2017.
Leveraging Social Media in the Stem Cell Sector: Exploring Twitter's Potential as a Vehicle for Public Information Campaigns.
Regenerative Medicine,
Vol. 12,
Issue. 7,
p.
753.
Budde, Björn
and
Konrad, Kornelia
2019.
Tentative governing of fuel cell innovation in a dynamic network of expectations.
Research Policy,
Vol. 48,
Issue. 5,
p.
1098.
Master, Z.
2019.
Encyclopedia of Biomedical Engineering.
p.
584.
Granados Moreno, Palmira
and
Joly, Yann
2021.
Principles of Translational Science in Medicine.
p.
389.